Published in
Elsevier, Journal of Allergy and Clinical Immunology: In Practice, 8(11), p. 2578-2580.e1, 2023
DOI: 10.1016/j.jaip.2023.05.019
Links
Tools
Anti–IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case series
Journal article published in 2023 by
Hanna Bonnekoh 
,
Lea Kiefer,
Thomas Buttgereit,
Pavel Kolkhir,
Marie Lütke-Eversloh,
Jörg Scheffel,
Marcus Maurer,
Martin Metz
,
Lea Kiefer,
Thomas Buttgereit,
Pavel Kolkhir,
Marie Lütke-Eversloh,
Jörg Scheffel,
Marcus Maurer,
Martin Metz
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 